Disputed patent rules dropped
A two-year battle between the US Patent and Trademark Office (USPTO) and biopharma over a much-contested set of patent rules ended yesterday (October 8) when the USPTO linkurl:rescinded the rules altogether.;http://www.uspto.gov/news/09_21.jsp "These regulations have been highly unpopular from the outset and were not well received by the applicant community," said David Kappos, director of the USPTO, in a statement. "In taking the actions we are announcing [October 8], we hope to engage the ap
**__Related stories:__***linkurl:New patent rules overturned;http://www.the-scientist.com/blog/display/54518/
[1st April 2008]*linkurl:Glaxo stalls new patent rules;http://www.the-scientist.com/blog/display/53814/
[31st October 2007]*linkurl:Big pharma sues USPTO;http://www.the-scientist.com/news/display/53705/
[16th October 2007] ]*linkurl:New patent rules hurt biotech?;http://www.the-scientist.com/news/display/53497/
[21st August 2007]

The Scientist ARCHIVES
Become a Member of
Meet the Author
Alla Katsnelson
This person does not yet have a bio.View full profile